Pošalji zapis e-poštom: PROSPECTIVE TRIAL INCORPORATING PRE-/MID-TREATMENT [(18)F]-MISONIDAZOLE POSITRON EMISSION TOMOGRAPHY FOR HEAD-AND-NECK CANCER PATIENTS UNDERGOING CONCURRENT CHEMORADIOTHERAPY